Document Details

Form
Filing Date
Jul 10, 2026
Document Date
Jul 9, 2026
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
UroGen Pharma, Ltd
Issuer
UroGen Pharma Ltd.
Filer
Schoenberg Mark